BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 37746851)

  • 1. Evaluation of the analytical and clinical performance of a new high-sensitivity cardiac troponin I assay: hs-cTnI (CLIA) assay.
    Li L; Shu X; Zhang L; Xu A; Yang J; Jing Y; Wang H; Zhang Z
    Clin Chem Lab Med; 2024 Jan; 62(2):353-360. PubMed ID: 37746851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trial design for assessing analytical and clinical performance of high-sensitivity cardiac troponin I assays in the United States: The HIGH-US study.
    Christenson RH; Peacock WF; Apple FS; Limkakeng AT; Nowak RM; McCord J; deFilippi CR
    Contemp Clin Trials Commun; 2019 Jun; 14():100337. PubMed ID: 30834354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic performance of a high-sensitivity cardiac troponin I assay in patients with non-ST-elevation acute coronary syndrome.
    Bohula May EA; Bonaca MP; Jarolim P; Antman EM; Braunwald E; Giugliano RP; Newby LK; Sabatine MS; Morrow DA
    Clin Chem; 2014 Jan; 60(1):158-64. PubMed ID: 24052087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical evaluation of Ortho Clinical Diagnostics high-sensitivity cardiac Troponin I assay in patients with symptoms suggestive of acute coronary syndrome.
    Kavsak PA; Mondoux SE; Sherbino J; Ma J; Clayton N; Hill SA; McQueen M; Mehta SR; Griffith LE; Devereaux PJ; Worster A
    Clin Biochem; 2020 Jun; 80():48-51. PubMed ID: 32304695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. European multicenter analytical evaluation of the Abbott ARCHITECT STAT high sensitive troponin I immunoassay.
    Krintus M; Kozinski M; Boudry P; Capell NE; Köller U; Lackner K; Lefèvre G; Lennartz L; Lotz J; Herranz AM; Nybo M; Plebani M; Sandberg MB; Schratzberger W; Shih J; Skadberg Ø; Chargui AT; Zaninotto M; Sypniewska G
    Clin Chem Lab Med; 2014 Nov; 52(11):1657-65. PubMed ID: 24897400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of sex-specific 99th percentile upper reference limits for a point of care high sensitivity cardiac troponin I assay.
    Apple FS; Schulz K; Schmidt CW; van Domburg TSY; Fonville JM; de Theije FK
    Clin Chem Lab Med; 2021 Aug; 59(9):1574-1578. PubMed ID: 34022125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analytical and clinical performance evaluation of a new high-sensitivity cardiac troponin I assay.
    Yang S; Zhang Q; Yang B; Li Z; Sun W; Cui L
    Clin Chem Lab Med; 2022 Jul; 60(8):1299-1307. PubMed ID: 35567358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of Age- and Sex-Specific 99th Percentile Upper Reference Limits for High-Sensitivity Cardiac Troponin I in Healthy Chinese Adults.
    He B; Wang K; Xu P; Zhou Q; Xu J
    Cardiology; 2022; 147(3):261-270. PubMed ID: 35220311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analytical and clinical characterization of a novel high-sensitivity cardiac troponin assay in a United States population.
    Christenson RH; Duh SH; Mullins KE; LeClair MM; Grigorov IL; Peacock WF
    Clin Biochem; 2020 Sep; 83():28-36. PubMed ID: 32485169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic and prognostic value of the sex-specific 99th percentile of four high-sensitivity cardiac troponin assays in patients with suspected myocardial infarction.
    Lehmacher J; Sörensen NA; Twerenbold R; Goßling A; Haller PM; Hartikainen TS; Schock A; Toprak B; Zeller T; Westermann D; Neumann JT
    Eur Heart J Acute Cardiovasc Care; 2024 Feb; 13(1):3-12. PubMed ID: 37890108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No increase in the incidence of cardiac troponin I concentration above the 99th percentile by Siemens Centaur high-sensitivity compared to the contemporary assay.
    Yang HS; Shemesh A; Li J; Xie T; Apple FS; Williams J; Zhao Z; Steel PAD
    Clin Biochem; 2021 Mar; 89():77-80. PubMed ID: 33296707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combining High-Sensitivity Cardiac Troponin I and Cardiac Troponin T in the Early Diagnosis of Acute Myocardial Infarction.
    van der Linden N; Wildi K; Twerenbold R; Pickering JW; Than M; Cullen L; Greenslade J; Parsonage W; Nestelberger T; Boeddinghaus J; Badertscher P; Rubini Giménez M; Klinkenberg LJJ; Bekers O; Schöni A; Keller DI; Sabti Z; Puelacher C; Cupa J; Schumacher L; Kozhuharov N; Grimm K; Shrestha S; Flores D; Freese M; Stelzig C; Strebel I; Miró Ò; Rentsch K; Morawiec B; Kawecki D; Kloos W; Lohrmann J; Richards AM; Troughton R; Pemberton C; Osswald S; van Dieijen-Visser MP; Mingels AM; Reichlin T; Meex SJR; Mueller C
    Circulation; 2018 Sep; 138(10):989-999. PubMed ID: 29691270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct comparison of clinical decision limits for cardiac troponin T and I.
    Kimenai DM; Henry RM; van der Kallen CJ; Dagnelie PC; Schram MT; Stehouwer CD; van Suijlen JD; Niens M; Bekers O; Sep SJ; Schaper NC; van Dieijen-Visser MP; Meex SJ
    Heart; 2016 Apr; 102(8):610-6. PubMed ID: 26794233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Evaluation of a New High-Sensitivity Cardiac Troponin I Assay for Diagnosis and Risk Assessment of Patients with Suspected Acute Myocardial Infarction.
    Shiozaki M; Inoue K; Suwa S; Lee CC; Chiang SJ; Sato A; Fukuda K; Kubota N; Tamura H; Fujiwara Y; Yamaguchi K; Sato T; Sumiyoshi M; Daida H
    Cardiology; 2021; 146(2):172-178. PubMed ID: 33461202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-sensitivity troponin in the evaluation of patients with suspected acute coronary syndrome: a stepped-wedge, cluster-randomised controlled trial.
    Shah ASV; Anand A; Strachan FE; Ferry AV; Lee KK; Chapman AR; Sandeman D; Stables CL; Adamson PD; Andrews JPM; Anwar MS; Hung J; Moss AJ; O'Brien R; Berry C; Findlay I; Walker S; Cruickshank A; Reid A; Gray A; Collinson PO; Apple FS; McAllister DA; Maguire D; Fox KAA; Newby DE; Tuck C; Harkess R; Parker RA; Keerie C; Weir CJ; Mills NL;
    Lancet; 2018 Sep; 392(10151):919-928. PubMed ID: 30170853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analytical validation of the Mindray CL1200i analyzer high sensitivity cardiac troponin I assay: MERITnI study.
    Fabre-Estremera B; Schulz K; Ladd A; Sexter A; Apple FS
    Clin Chem Lab Med; 2024 May; ():. PubMed ID: 38801528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic performance of a rapid, novel, whole blood, point of care high-sensitivity cardiac troponin I assay for myocardial infarction.
    Gunsolus IL; Schulz K; Sandoval Y; Smith SW; Lindgren B; Okeson B; Apple FS
    Clin Biochem; 2022; 105-106():70-74. PubMed ID: 35447148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the new Beckman Coulter Access hsTnI: 99th percentile upper reference limits according to age and sex in the Korean population.
    Kim S; Yoo SJ; Kim J
    Clin Biochem; 2020 May; 79():48-53. PubMed ID: 32059836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reference values of galectin-3 and cardiac troponins derived from a single cohort of healthy blood donors.
    Mueller T; Egger M; Leitner I; Gabriel C; Haltmayer M; Dieplinger B
    Clin Chim Acta; 2016 May; 456():19-23. PubMed ID: 26920637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis of type 1 and type 2 myocardial infarction using a high-sensitivity cardiac troponin I assay with sex-specific 99th percentiles based on the third universal definition of myocardial infarction classification system.
    Sandoval Y; Smith SW; Schulz KM; Murakami MM; Love SA; Nicholson J; Apple FS
    Clin Chem; 2015 Apr; 61(4):657-63. PubMed ID: 25672334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.